Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06149143 · ClinicalTrials.gov registry record
Cardiac Performance System Data Collection Study - Minnesota
A clinical trial of Cardiac Disease, sponsored by Sensydia Corporation.
- Recruiting
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT06149143: Recruiting study of Cardiac Disease, sponsored by Sensydia Corporation.
NCT06149143 is a study of Cardiac Disease that is actively recruiting participants, run by Sensydia Corporation. The registered enrollment target is 50 participants, below the 820-participant average among 24 other Cardiac Disease trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06149143, a study of Cardiac Disease, is actively recruiting participants, sponsored by Sensydia Corporation.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Non-significant risk device study to conduct evaluation of the performance of new device for monitoring of cardiac function (based on previous iterations 510(k) 173156)
Conditions Studied
Interventions
- DEVICE Cardiac Performance System (NSR)
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-10-03 |
| Est. Completion | 2024-06-30 |
What NCT06149143 shows while recruiting
NCT06149143 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 820-participant average among 24 other Cardiac Disease trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Cardiac Disease appearing as the primary indexed condition, and to 1 intervention - of which Cardiac Performance System (NSR) is the first listed.
NCT06149143 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT06149143 about?
NCT06149143 is a clinical study titled "Cardiac Performance System Data Collection Study - Minnesota". Non-significant risk device study to conduct evaluation of the performance of new device for monitoring of cardiac function (based on previous iterations 510(k) 173156)
What is the current status of trial NCT06149143?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2023-10-03. Estimated completion is 2024-06-30.
What conditions does trial NCT06149143 study?
This clinical trial studies the following conditions: Cardiac Disease.
What interventions are being tested in trial NCT06149143?
The interventions under investigation include: Cardiac Performance System (NSR) (DEVICE).
Who is sponsoring clinical trial NCT06149143?
This trial is sponsored by Sensydia Corporation, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06149143 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiac Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06149143's enrollment target sits among peer trials
50 23rd of 24 higher than 2 of 24 other Cardiac Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiac Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of Electrocardiogram and Focused Cardiac Ultrasound for Enhanced Cardiac Disease Screening
RECRUITING
-
Fresh Autologous Whole Blood Transfusion After Cardiopulmonary Bypass
RECRUITING · NA
-
Rectus Sheath Block in Cardiac Surgery
RECRUITING · NA
-
Opportunistic PK/PD Trial in Critically Ill Children (OPTIC)
RECRUITING
-
Factor VIII Inhibitor Bypass Activity (FEIBA) Versus Fresh Frozen Plasma As First Line Therapy For Bleeding After Cardiac Surgery
RECRUITING · Phase 2
-
The Effectiveness of 4D Image Acquisition and Post-processing With Vios Works
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI